Firstly, it is divided into two parts: 1. It is normal for China not to copy the original drug during the patent period, because China has a lot of trade in the world trade, and it will be sanctioned in other aspects if it does not comply with the rules. India used to be barefoot and not afraid to wear shoes, so he copied it during the patent period of the original drug research. Later, with the continuous increase of his foreign trade, countries imposed sanctions on him for this matter, so now India is not too afraid of copying drugs within the patent period. 2. Generic drugs with expired patents are available in all countries, such as Gleevec before, and also in China. However, for various reasons, it is a fact that China is not as good as India in generic drugs. India is now the world's pharmacy, because when there was little world trade, it copied a large number of original drugs during the patent period, which improved its imitation ability. In this respect, what China did before was not as good as all kinds of developed generic drugs, and now it is catching up. But in the research and development of original drugs, this country has always been the world leader.

Criminal law of the people's Republic of China

Article 225

The crime of illegal business operation violates the provisions of the state and commits one of the following illegal business operations, disrupting the market order, and if the circumstances are serious, it shall be sentenced to fixed-term imprisonment of not more than five years or criminal detention, and shall also, or shall only, be fined not less than one time but not more than five times the illegal income; If the circumstances are especially serious, he shall be sentenced to fixed-term imprisonment of not less than five years, and shall also be fined not less than one time but not more than five times for illegal gains or confiscation of property:

(a) operating a franchise or monopoly commodity or other commodities whose operation is restricted by laws and administrative regulations without permission;

(2) buying and selling import and export licenses, import and export certificates of origin and other business licenses or approval documents stipulated by laws and administrative regulations;

(three) without the approval of the relevant competent departments of the state, illegally engaged in securities, futures, insurance business, or illegally engaged in fund payment and settlement business;

(four) other illegal business activities that seriously disrupt the market order.